Carmichael Hill & Associates’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
$10.3K Buy
148
+75
+103% +$4.51K ﹤0.01% 584
2024
Q2
$3.86K Buy
+73
New +$4.43K ﹤0.01% 659

Other funds holding SOLV

Carmichael Hill & Associates's SOLV Position: Q3 2024 in Review

Carmichael Hill & Associates increased its Solventum (SOLV) stake by 103% in Q3 2024, buying an estimated $4.51K and bringing the position to 148 shares worth $10.3K. The position accounts for ﹤0.01% of the portfolio, ranked #584.

Carmichael Hill & Associates first reported a position in SOLV in Q2 2024 and has held it in 2 quarters since. 936 funds tracked by Wall St. Rank hold SOLV as of Q3 2024.

  • Carmichael Hill & Associates held 148 shares of Solventum worth $10.3K as of Q3 2024.
  • Carmichael Hill & Associates bought 75 Solventum shares in Q3 2024, an estimated $4.51K.
  • Solventum made up ﹤0.01% of Carmichael Hill & Associates's portfolio in Q3 2024, its #584 holding.
  • Carmichael Hill & Associates first reported a position in Solventum in Q2 2024 and has held it in 2 quarters since.
  • 936 funds tracked by Wall St. Rank held Solventum as of Q3 2024.

Based on Carmichael Hill & Associates's 13F filing for Q3 2024, filed 29 Oct 2024.